In 2007, the Norwegian Film Institute presented Nicolai Cleve Broch as a Shooting Star at the Berlin Film Festival. Nearly two decades later, he is part of the ensemble behind Nepobaby, the TV 2 drama that drew 1.1 million viewers and broke TV 2 Play’s records in 2025.
His is a career of steady reinvention: Nationaltheatret stalwart, wartime resistance fighter on film, time-travel detective on HBO, and now an heir to a shipping empire. His finances, however, are another matter.
As of October 26, 2026, Nicolai Cleve Broch’s net worth has not been publicly confirmed. We found no estimate from Forbes, the Norwegian business magazine Kapital or any other established financial outlet. This article sets out what is known, what circulates online without support, and why we remain cautious.
Nicolai Cleve Broch Net Worth 2026: What Is Actually Known
One biography site, TheCityCeleb, lists an estimated net worth of USD 3 million. It gives no source, no method and no as-of date, and its only explanation is that his income comes from acting and voice work. We treat the number as unverified and low-confidence, and we would not quote it as fact.
We also looked for a personal holding company, which in Norway can offer a view of an actor’s business finances. We found no filings tied to him. A company called Cleve Broch AS does exist, but it is registered for architectural activities with different named managers, and nothing links it to the actor, so we do not use it.
There is a structural limit as well. Norway publishes annual tax lists, but DNB explains that these show taxable net income and net wealth, which differ from salary and reveal only part of what someone owns. A tax-list figure alone would not be a net worth.
What we can say is limited. Broch has been at Nationaltheatret since 2005, according to Wikipedia, and SNL lists freelance stage work alongside it. We found no verified reporting on his salary, fees, endorsements, property or investments, so we do not guess.
Quick Facts
| Detail | Information |
|---|---|
| Full name | Nicolai Cleve Broch |
| Born | November 14, 1975 |
| Age (October 2026) | 50 |
| Birthplace | Bærum per Wikipedia; Oslo per his own website |
| Nationality | Norwegian |
| Profession | Actor (stage, film, television) |
| Education | Norwegian National Academy of Theatre (1996–1999) |
| Best-known work | Max Manus, Beforeigners, Uro, Frikjent, Nepobaby, Morden i Sandhamn |
| Honours | Berlinale Shooting Star (2007); Amanda nominations (2007, 2008 film year); Canneseries ensemble prize for Nepobaby (2025) |
| Family | Married to actress Heidi Gjermundsen Broch; two sons; half-brother of actress Ida Elise Broch |
| Net worth | Not publicly confirmed (unverified web estimate: USD 3 million) |
Early Life and Training
Broch was born on November 14, 1975. Sources disagree on where: Wikipedia says Bærum, while his own biography page says Oslo. That page adds an amusing detail: he briefly studied history at the University of Oslo, and left on the first day.
He then trained at the Norwegian National Academy of Theatre from 1996 to 1999, per Store norske leksikon (SNL). His stage debut was in Hjalmar og Frode.
Career Highlights
Stage: Nationaltheatret and Beyond
SNL traces his early theatre path through Oslo Nye Teater (1999–2002), Det Norske Teatret (2003–2005) and the role of Saint Olav at Stiklestad (2004). From 2005 he joined Nationaltheatret, where he played Emperor Julian in Emperor and Galilean.
Later work includes Bedrag at Riksteatret (2013) and Closer (2017). His website lists Rain Man at Christiania Theater in early 2024, in which he played Charlie Babbitt, and photos from a 2026 production of An Enemy of the People, though it gives no details.
Early Recognition
In 2002 Dagbladet named him “Theatre Talent of the Year”, and he received a Gullruten nomination for Best Male Actor for the NRK series Lekestue. In 2006 he starred in Uro, which screened in Cannes’ Un Certain Regard section and brought an Amanda nomination for Best Actor. Wikipedia and his own site also list a second Amanda nomination, for supporting work in Max Manus. Both record nominations, not wins.
Max Manus and Film
Broch played Gregers Gram in the wartime film Max Manus (2008). He also appeared in Buddy (2003), Uno (2004), Lønsj (2007), Den siste revejakta (2008) and Kielergata (2018), according to Wikipedia’s filmography.
Television: Frikjent, Beforeigners and Sandhamn
On television he starred in Frikjent (2015–2016) and then took the role of Oslo police detective Lars Haaland in HBO’s time-travel drama Beforeigners. According to Wikipedia, season one ran from August to September 2019 and season two from December 2021. The page records that Norway’s film and TV incentive scheme granted NOK 9.5 million for season one and NOK 22.3 million for season two. These are public production grants, not budgets and certainly not his pay.
He also plays Alexander Forsman in the Swedish crime series Morden i Sandhamn, which Wikipedia lists from 2020.
Nepobaby
His recent breakthrough in ensemble drama is Nepobaby, created by Henriette Steenstrup and Siri Seljeseth for TV 2. A sales report hosted by AOL says he plays one of the wealthy siblings, heirs of shipping magnate Ludvig “Doddo” Bullmann. At Canneseries 2025, the series won Best Screenplay and the ensemble cast received a Special Interpretation Award, according to his biography.
Season two was announced for August 28 on TV 2 Play, with Broch listed among the returning cast, per Nordic Widescreen.
Earnings and Money: What We Can and Cannot Say
No contract, salary or per-episode fee has been reported for Broch. Norwegian broadcasters and theatres rarely publish pay, and we found no verified endorsement deals.
It would be tempting to read Nepobaby‘s viewership records or Beforeigners‘ public grants as signs of a large income. They are not. Viewership measures audience, grants measure production funding, and neither shows what an individual actor was paid.
Because he splits his time between a stage ensemble, television and film, his income is likely varied, but we have no documents to quantify it, so we leave it there.
Personal Life
Broch is married to actress Heidi Gjermundsen Broch, who is known for Piaf and Mamma Mia!. They have two sons, and one, Jørgen, is also an actor. He is also the half-brother of actress Ida Elise Broch. We found no verified reporting on property or lifestyle spending.
Frequently Asked Questions
What is Nicolai Cleve Broch’s net worth in 2026?
It has not been publicly confirmed. We found no Forbes or Kapital estimate. One biography site cites USD 3 million without any source or date, so treat it as unverified.
How old is Nicolai Cleve Broch?
He was born on November 14, 1975, which makes him 50 as of October 2026.
What is Nicolai Cleve Broch best known for?
He is best known for Max Manus, the HBO series Beforeigners, Frikjent, Morden i Sandhamn and the TV 2 drama Nepobaby.
Is Nicolai Cleve Broch related to Ida Elise Broch?
Yes. Wikipedia describes actress Ida Elise Broch as his half-sister.
Who is Nicolai Cleve Broch married to?
He is married to actress Heidi Gjermundsen Broch, and they have two sons.
Final Thoughts
Nicolai Cleve Broch has quietly built a career across stage, film and the Nordic streaming boom, moving between Ibsen-era theatre and prestige TV without ever becoming a tabloid fixture. That privacy is part of why his finances are not documented. Until a credible outlet publishes a sourced figure, the honest answer to “Nicolai Cleve Broch net worth 2026” is that it is unconfirmed. We will update this article if reliable data appears.
Sources & References
- Nicolai Cleve Broch, Wikipedia
- Nicolai Cleve Broch, Store norske leksikon (SNL)
- Nicolai Cleve Broch, official biography (self-published)
- Beforeigners, Wikipedia
- First look, trailer and premiere date for Nepobaby season two, Nordic Widescreen
- Henriette Steenstrup’s Nepobaby racks up sales ahead of Mipcom, via AOL
- Nepobaby, Canneseries
- Skattelistene viser ikke hva naboen eller kollegaen tjener, DNB
- TheCityCeleb biography page (cited only as the source of the unverified USD 3 million claim)
Note: Net worth estimates are not official financial statements. Information is based on publicly available sources as of October 26, 2026.
